Moreover, to prevent diagnostic delay and ensure optimal treatment strategies, testing of MOG-Ig in serum, including MOG-IgA as recently described (3), should be considered in patients not only with suspected neurosyphilis but also in patients with syphilis infection and indications of a demyelinating event. The gene discussed is CD79A; the disease is neurosyphilis.